Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging (Q43666964)

From Wikidata

Jump to navigation Jump to search

scientific article published in July 2001

Language	Label	Description	Also known as
English	Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging	scientific article published in July 2001

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

author name string

U G Mueller-Lisse

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

M G Swanson

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

D B Vigneron

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

H Hricak

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

A Bessette

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

R G Males

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

P J Wood

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

S Noworolski

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

S J Nelson

9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

I Barken

10

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

P R Carroll

11

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

J Kurhanewicz

12

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Magnetic Resonance in Medicine

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

49-57

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Pathological changes in prostate lesions after androgen manipulation

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Why neoadjuvant androgen deprivation prior to radical prostatectomy is unnecessary

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Mechanistic concepts in androgen-dependence of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

The biology of hormone refractory prostate cancer. Why does it develop?

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

The prostate: MR imaging and spectroscopy. Present and future

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Spatial localization in NMR spectroscopy in vivo

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Improved water and lipid suppression for 3D PRESS CSI using rf band selective inversion with gradient dephasing (basing)

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Surface coil MR imaging of the human brain with an analytic reception profile correction.

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Hormonal ablation of prostatic cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Effects of combination endocrine treatment on normal prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Concepts of citrate production and secretion by prostate: 2. Hormonal relationships in normal and neoplastic prostate

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Intermittent androgen deprivation in prostate cancer patients: factors predictive of prolonged time off therapy

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer: results of a phase II study

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2-3 N0 M0 prostatic carcinoma. The European Study Group on Neoadjuvant Tr

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Detection of recurrent prostate cancer after cryosurgery.

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Testosterone regulates pyruvate dehydrogenase activity of prostate mitochondria

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Testosterone stimulates the biosynthesis of m-aconitase and citrate oxidation in prostate epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Testosterone and prolactin stimulation of mitochondrial aconitase in pig prostate epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Magnetic resonance imaging of the efficacy of specific inhibition of 5α-reductase in canine spontaneous benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report

1 reference

https://api.crossref.org/works/10.1002%2FMRM.1159

21 January 2018

Identifiers

10.1002/MRM.1159

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43666964&oldid=2102394801"